Related Experiment Video
Updated: Apr 6, 2026
06:04
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
3.0K
Macrolide-Resistant Mycoplasma pneumoniae, United States
Emerging Infectious Diseases
|July 22, 2015
Summary
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is emerging in the US, with high-level resistance detected in over 13% of samples. This finding highlights the need for increased surveillance of this resistant bacterial strain.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Macrolide-resistant Mycoplasma pneumoniae (MRMP) is a growing global health concern, prevalent in Asia and increasingly reported in Europe.
- Limited data exists on the prevalence and characteristics of MRMP within the United States.
Purpose of the Study:
- To investigate the prevalence of high-level macrolide resistance in Mycoplasma pneumoniae in the United States.
- To characterize the resistance patterns of Mycoplasma pneumoniae strains in the US.
Main Methods:
- Genotypic methods were employed to detect resistance mechanisms.
- Phenotypic methods were utilized to confirm macrolide resistance.
- Analysis of 91 Mycoplasma pneumoniae-positive specimens from six diverse US locations.
Main Results:
- High-level macrolide resistance was detected in 13.2% of the analyzed Mycoplasma pneumoniae specimens.
- The study identified MRMP in multiple geographic regions across the United States.
- The prevalence indicates a significant presence of resistant strains in the US population.
Conclusions:
- Macrolide-resistant Mycoplasma pneumoniae is present at a significant level in the United States.
- The findings underscore the urgent need for enhanced surveillance and diagnostic strategies for MRMP in the US.
- This resistance poses a potential challenge for the effective treatment of Mycoplasma pneumoniae infections.
More Related Videos
Related Concept Videos
01:14Atypical Pneumonia
49
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
49
01:25Mechanism of Antibiotic Resistance in MRSA
115
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
115
01:25Clinical Significance of Antibiotic Resistance
43
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
43
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:30Pneumonia V: Nursing management and Prevention
4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
01:28Antimicrobial Effectiveness
2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K